Acer Therapeutics Inc.
ACER
|
$0.9
-3.61%
420K
|
Health Technology
(0.0% 1d) (0.0% 1m) (3.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1077.06% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 22,017,353
http://www.acertx.com
Sec Filling | Patents | 17 employees
(US) Acer Therapeutics, Inc. is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling on September 19, 2017 and is headquartered in Newton, MA.
acquisitions urine urea treatment
add to watch list Paper trade email alert is off
Press-releases
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
Published: 2023-11-20 (Crawled : 12:30) - globenewswire.com
ZVRA | $4.57 -0.22% -0.22% 160K
|
n/a
|
| O: 1.38%
H: 2.27%
C: 1.82%
rare disease company acquisition therapeutics
Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceuticals plc; Biocept, Inc.; Akumin Inc.; Appreciate Holdings, Inc.; Liberty TripAdvisor Holdings, Inc.; Tempo Automation Holdings, Inc.; Medicenna Therapeutics Corp.; RiceBran Technologies; and Acer Therapeutics Inc. from The Nasdaq Stock Market
Published: 2023-11-17 (Crawled : 21:00) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
| Email alert
Add to watchlist
AKU | $0.2887 -0.42% 8.5M
|
Health Services
| Email alert
Add to watchlist
BIOC | $0.4349 -10.32% 750K
|
Health Services
| Email alert
Add to watchlist
INFI | $0.016 12.5% 1.1M
|
Health Technology
| Email alert
Add to watchlist
KRBP | $2.64 -90.21% 360
|
Health Technology
| Email alert
Add to watchlist
LTRPA | $1.33 5.37% 320K
|
Consumer Services
| Email alert
Add to watchlist
LTRPB | $10.5 -27.62% 53K
|
Consumer Services
| Email alert
Add to watchlist
MDNA | $0.157 -0.32% 1.3M
|
Health Technology
| Email alert
Add to watchlist
NDAQ | $61.51 0.69% 0.68% 2.8M
|
Finance
| Email alert
Add to watchlist
OTRK 4 | $0.3308 -4.45% -4.66% 920K
|
Health Services
| Email alert
Add to watchlist
RIBT 4 | $0.18 -12.78% 860
|
Consumer Non-Durables
| Email alert
Add to watchlist
SFT | $0.1703 -23.66% 180M
|
Finance
| Email alert
Add to watchlist
FXCO | $11.0 0.91% 2.7K
|
n/a
| Email alert
Add to watchlist
GGAA | $21.57 2.1M
|
n/a
| Email alert
Add to watchlist
RVLP | $0.0282 -20.92% 64M
|
Manufacturing
| Email alert
Add to watchlist
INFIQ | $0.0001 3000.0% 680
|
Manufacturing
| Email alert
Add to watchlist
MDNAF | $1.14 -17.54% 58K
|
n/a
| Email alert
Add to watchlist
tempo acquisition pharmaceuticals liberty therapeutics financial growth market
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
ZVRA | $4.57 -0.22% -0.22% 160K
|
n/a
|
| O: 1.35%
H: 1.77%
C: -2.22%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -1.64%
H: 1.8%
C: 0.59%
glass therapeutics
Moore Kuehn Encourages TWNK, LVOX, ACER, and PNT Investors to Contact Law Firm
Published: 2023-10-13 (Crawled : 19:00) - prnewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
| Email alert
Add to watchlist
TWNK | $33.3 0.07% 53M
|
Consumer Non-Durables
| Email alert
Add to watchlist
NICE | News | $230.6 0.95% 0.94% 170K
|
Technology Services
| Email alert
Add to watchlist
VIRT | $21.83 3.02% 2.93% 2.5M
|
Finance
| Email alert
Add to watchlist
LVOX 4 | $3.73 0.0% 320K
|
| Email alert
Add to watchlist
PNT | $13.68 2.63% 0.15% 0
|
| Email alert
Add to watchlist
NCSYF | News | $227.0 -29.01% 1
|
n/a
| Email alert
Add to watchlist
moore
Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
Published: 2023-08-31 (Crawled : 18:00) - acertx.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 70.49%
H: 0.0%
C: 0.0%
europe worldwide commercialization therapeutics
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
Published: 2023-08-31 (Crawled : 12:00) - globenewswire.com
ZVRA | $4.57 -0.22% -0.22% 160K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -4.34%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 70.49%
H: 0.0%
C: 0.0%
rare disease acquire commercial therapeutics
Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
Published: 2023-08-30 (Crawled : 20:00) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 70.49%
H: 0.0%
C: 0.0%
europe worldwide commercialization therapeutics
Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-14 (Crawled : 20:00) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -18.79%
H: 7.81%
C: -0.16%
update therapeutics financial results
Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 1.14%
H: 5.62%
C: -2.24%
therapeutics
Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
Published: 2023-05-15 (Crawled : 21:00) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -0.03%
H: 4.13%
C: 2.58%
update therapeutics financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10